The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

By Philipp M.T.   Lobet Y.   Bohm R.P.   Roberts E.D.   Dennis V.A.   Gu Y.   Lowrie R.C.   Desmons P.   Duray P.H.   England J.D.   Hauser P.   Piesman J.   Xu K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1872-1887

Elsevier

Access to resources Recommend Favorite

Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2

By Johnson B.J.B.   Sviat S.L.   Happ C.M.   Dunn J.J.   Frantz J.C.   Mayer L.W.   Piesman J.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1086-1094

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite